All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F07%3A00004163" target="_blank" >RIV/61989592:15110/07:00004163 - isvavai.cz</a>

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women

  • Original language description

    OBJECTIVE: Continuous combined hormone replacement therapy (ccHRT) based on estradiol valerate (E2V) and medroxyprogesterone acetate (MPA) is effective for relief of menopausal symptoms three years or more after the menopause. This study was undertaken to examine the efficacy and tolerability of ccHRT in early postmenopausal women (last menstrual period 1.3 years before study entry). STUDY DESIGN: This was a 52-week, randomized, double-blind, multinational study of ccHRT comprising three different dosecombinations of E2V/MPA in 459 early postmenopausal non-hysterectomized women experiencing 30 or more moderate to severe hot flushes a week and/or vasomotor symptoms requiring treatment. MAIN OUTCOMES MEASURES: The primary endpoint was change in frequency and severity of moderate to severe hot flushes at 12 weeks. Secondary outcome measures included number of bleeding days and evaluation of tolerability. RESULTS: The frequency of hot flushes was reduced by >or=70% after one month (P<0.00

  • Czech name

    Účinnost a snášenlivost kontinuální kombinované hormonální substituční terapie u časně postmenopauzálních žen

  • Czech description

    Kontinuální kombinovaná hormonální substituční terapie (HST) s estradiol valerátem a medroxyprogesteron acetátem byla ověřována v 1 rok trvající, randomizované a dvojitě zaslepené mezinárodní klinické studii, do které bylo zahrnuto 459 žen krátce po menopause. Tato HRT byla efektivní pro potlačení klimakterických symptomů a byla dobře tolerována.

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FK - Gynaecology and obstetrics

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2007

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Menopause International

  • ISSN

    1754-0453

  • e-ISSN

  • Volume of the periodical

    13

  • Issue of the periodical within the volume

    3

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    8

  • Pages from-to

    124-131

  • UT code for WoS article

  • EID of the result in the Scopus database